The recent pandemic, in one way, is like the WWIII we were hoping would never come.…
Category: Primers
Safety in Spine Surgery Award Winners Announced
The Safety in Spine Surgery Project (S3P) has announced the Best New Methodologies and Techniques to…
Eiger BioPharmaceuticals Reports Fourth Quarter and Full Year 2020 Financial Results and Provides Business Update
Eiger BioPharmaceuticals, Inc. (Nasdaq: EIGR), a commercial-stage biopharmaceutical stage company focused on the development and commercialization of…
Vivor Expands Executive Team; Hires Precision Medicine Veteran as Head of Sales
Vivor, the market-leading patient financial assistance platform, is pleased to announce that Erin Scales has joined their leadership…
Kansas Health Science Center Board of Trustees Presents Commendation to President Michele Nealon of The Chicago School of Professional Psychology
The Kansas Health Science Center (KHSC) Board of Trustees is recognizing President Michele Nealon, Psy.D., of The Chicago School of…
Karmanos Cancer Institute Recognizes March as Colorectal Cancer Awareness Month
The Barbara Ann Karmanos Cancer Institute, along with cancer centers and other organizations across the nation,…
Canada Drugs Direct: Order Rx Meds From Canada to Avoid 2x Higher Prescription Drugs Prices in U.S.
The continual rise of prescription drug costs in America sees the average person spend around $1200 per year, more than…
innovent Announces First Patient Outside China Dosed in the Phase 1 Clinical Trial of Anti-CD47/PD-L1 Bispecific Antibody
Innovent Biologics, Inc. (“Innovent”) (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high…
Everest Medicines Announces Selection as a Constituent of Certain Indexes of Hang Seng Indexes Company Limited
Everest Medicines (HKEX 1952.HK), a biopharmaceutical company focused on developing and commercializing transformative pharmaceutical products that…
WuXi Diagnostics Secures US$150 Million Series B Financing to Accelerate Market Penetration in Global Diagnostics Sector
WuXi Diagnostic Investment (Cayman) Limited (“WuXi Diagnostics”) announced that it has completed US$150 million in series B funding, joined…